Funding · Company
Cellanome, Inc.
Palo Alto, CABiotech & Pharma
Cellanome, Inc. of Palo Alto, CA has disclosed $288M across 4 Form D offerings filed with the SEC between Dec 6, 2021 and Jun 22, 2026.
$288M
Total disclosed
4
Form D offerings
6
Open roles today
Hiring — 6 open roles as of Nov 6, 2026
Based in Foster City, CA, San Diego, CA. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$41M
Form D · Mar 21, 2023 ↗
Q1 2023
· 1 amendment, first filed Aug 5, 2022
Filing details
HeadquartersPalo Alto, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0001886462Offerings on file4
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →